Thogotovirus
Thogotovirus is a genus of viruses within the family Orthomyxoviridae, which is known for containing viruses that primarily infect vertebrate hosts, including humans and other mammals, as well as invertebrates such as ticks and mosquitoes. Thogotoviruses are arboviruses, meaning they are transmitted by arthropod vectors. The genus includes several species, with Thogoto virus and Dhori virus being among the most studied due to their potential to cause disease in humans and animals.
Structure and Genome[edit]
Thogotoviruses are enveloped viruses with a segmented, single-stranded, negative-sense RNA genome. The genome typically consists of six segments, encoding for at least six proteins, including the surface glycoproteins involved in virus attachment to host cells, and the internal proteins responsible for viral replication and assembly. The structure of Thogotoviruses is similar to other members of the Orthomyxoviridae family, featuring a spherical to pleomorphic shape with a diameter ranging from 80 to 120 nm.
Transmission and Epidemiology[edit]
Thogotoviruses are transmitted to vertebrates through the bite of infected arthropods, primarily ticks and mosquitoes. The distribution of Thogotoviruses is worldwide, with specific viruses having been identified in various geographical locations, including Africa, Asia, Europe, and North America. The prevalence and incidence of Thogotovirus infections in humans and animals are not well-documented, partly due to the lack of widespread surveillance and the non-specific nature of the symptoms associated with infection.
Pathogenesis and Clinical Features[edit]
In humans, Thogotovirus infections can range from asymptomatic to causing flu-like symptoms, such as fever, fatigue, muscle aches, and headaches. Severe cases, although rare, can lead to encephalitis, meningitis, or hemorrhagic fever, posing significant health risks. The pathogenesis of Thogotovirus infections involves the virus entering the host through the skin, followed by replication in local tissues and dissemination to various organs, including the central nervous system in severe cases.
Diagnosis and Treatment[edit]
Diagnosis of Thogotovirus infections is primarily based on the detection of viral RNA, antibodies against the virus, or virus isolation from clinical specimens. Molecular techniques such as reverse transcription-polymerase chain reaction (RT-PCR) are commonly used for viral RNA detection. Treatment is mainly supportive, focusing on the management of symptoms, as there are no specific antiviral therapies approved for Thogotovirus infections. Prevention strategies include avoiding bites from ticks and mosquitoes and controlling vector populations.
Research and Future Directions[edit]
Research on Thogotoviruses is ongoing, with studies focusing on understanding the virus's molecular biology, pathogenesis, and interactions with both vertebrate hosts and invertebrate vectors. The development of vaccines and specific antiviral treatments against Thogotoviruses is an area of interest, given the potential for these viruses to cause disease in humans and animals. Additionally, surveillance and research efforts are aimed at identifying new Thogotovirus species and understanding their epidemiology and potential impact on public health.
-
Thogotovirus
-
Thogotovirus virion
-
Thogotovirus genomes
-
Thogotovirus glycoprotein comparison
-
Thogotovirus
-
Thogotovirus phylogeny
-
Hyalomma marginatum
-
Thogotovirus
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian